Chitosan-chondroitin sulfate based matrix tablets for colon specific delivery of indomethacin

AAPS PharmSciTech

Volumn 10, Issue 2, 2009, Pages 670-677

  Amrutkar, Jitendra R ^a   Gattani, Surendra G ^a  

^a R C PATEL INSTITUTE OF PHARMACEUTICAL EDUCATION AND RESEARCH   (India)

Author keywords

Chitosan; Chondroitin sulfate; Colonic delivery; Cross linking; Indomethacin

Indexed keywords

CHITOSAN; CHONDROITIN SULFATE; INDOMETACIN; CHITOSAN SULFATE;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CROSS LINKING; DIFFERENTIAL SCANNING CALORIMETRY; DRUG COATING; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG GRANULATION; DRUG RELEASE; DRUG SOLUBILITY; IN VITRO STUDY; INFRARED SPECTROSCOPY; MALE; MATRIX TABLET; NONHUMAN; RAT; X RAY POWDER DIFFRACTION; ANIMAL; CHEMISTRY; COLON; METABOLISM; SOLUBILITY; TABLET; WISTAR RAT; X RAY DIFFRACTION;

ANIMALS; CALORIMETRY, DIFFERENTIAL SCANNING; CHEMISTRY, PHARMACEUTICAL; CHITOSAN; COLON; DRUG DELIVERY SYSTEMS; INDOMETHACIN; MALE; RATS; RATS, WISTAR; SOLUBILITY; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; TABLETS; X-RAY DIFFRACTION;

EID: 67549117212     PISSN: None     EISSN: 15309932     Source Type: Journal    
DOI: 10.1208/s12249-009-9253-y     Document Type: Article

References (25)

1. Gupta K, Beckert TE, Price JC. A novel pH- and time-based multi-unit potential colonic drug delivery system. I. Development. Int J Pharm. 2001;213:83-91.
2. Rodriguez M, Vila-Jato JL, Torres D. Design of a new multiparticulate system for potential site-specific and controlled drug delivery to the colonic region. J Control Release. 1998;55:67-77.
3. Khan MZ, Prebeg Z, Kurjakovic N. A pH-dependent colon targeted oral drug delivery system using methacrylic acid copolymers. I. Manipulation of drug release using Eudragit L100-55 and Eudragit S100 combinations. J Control Release. 1999;58:215-22.
4. Davis SS, Hardy JG, Taylor MJ, Stockwell A, Whalley DR, Wilson CG. The in vivo evaluation of an osmotic device (Osmet) using gscintigraphy. J Pharm Pharmacol. 1984;36:740-2.
5. Ashford M, Fell JT, Attwood D, Sharma HL, Woodhead PJ. An in vivo investigation into the suitability of pH dependent polymers for colonic targeting. Int J Pharm. 1993;95:193-9.
6. Evans DF, Pye G, Bramely R, Clark AG, Dysoa TJ. Measurement of gastrointestinal pH profiles in normal ambulant human subjects. Gut. 1988;29:1035-41.
7. Sinha VR, Kumria R. Colonic drug delivery: Prodrug approach. Pharm Res. 2001;18:557-64.
8. Sinha VR, Kumria R. Polysaccharides for colon specific drug delivery. Int J Pharm. 2001;224:19-38.
9. Hovgaard L, Brondsted H. Current applications of polysaccharides in colon targeting. Crit Rev Ther Drug Carrier Syst. 1996;13:185-223.
10. Sinha VR, Kumria R. Binders for Colon specific drug delivery: An in vitro evaluation. Int J Pharm. 2002;249:23-31.
11. Tapia C, Escobar Z, Costa E, Hagar J, Valenzuela F, Basualto C, et al. Comparative studies on polyelectrolyte complex and mixtures of chitosan-carageenan as prolonged diltiazem clorhydrate release systems. Eur J Pharm Biopharm. 2004;57:65-75.
12. Hull MA, Gardner H, Hawcroft G. Activity of the non-steroidal anti-inflammatory drug indomethacin against colorectal cancer. Cancer Treat Rev. 2003;29:309-20.
13. Kapitanovic S, Cacev T, Antica M, Kralj M, Cavric G, Pavelic K, et al. Effect of indomethacin on E-cadherin and β-catenin expression in HT-29 colon cancer cells. Exp Mol Pathol. 2006;80:91-6.
14. Chourasia MK, Jain SK. Pharmaceutical approaches to colon targeted drug delivery systems. J Pharm Sci. 2003;6(1):33-66.
15. Aulton ME, Wells TI, editors. The science of dosage form design. London, UK: Churchill Livingstone; 1988.
16. Government of India Ministry of Health and Family Welfare. The pharmacopoeia of India. Delhi, India: Controller of Publication; 2007.
17. Krishnaiah YSR, Bhaskar Reddy PR, Satyanarayana V, Karthikeyan RS. Studies on the development of oral colon targeted drug delivery systems for metronidazole in the treatment of amoebiasis. Int J Pharm. 2002;236:43-55.
18. Krishnaiah SR, Satyanarayana S, Rama Prasad YV, Narasimha Rao S. Evaluation of gaur gum as a compression coat for drug targeting to colon. Int J Pharm. 1998;171:137-46.
19. Macfarlane GT, Hay S, Macfarlane S, Gibson GR. Effect of different carbohydrates on growth, polysaccharidase and glycosidase production by Bacteroides ovatus, in batch and continuous culture. J Appl Bacteriol. 1990;68(2):179-87.
20. Higuchi T. Mechanism of sustained-action medication: Theoretical analysis of rate of release of solid drugs dispersed in solid matrices. J Pharm Sci. 1963;52:1145-9.
21. Korsmeyer RW, Gurny R, Docler E, Buri P, Peppas NA. Mechanism of solute release from porous hydrophilic polymers. Int J Pharm. 1983;15:25-35.
22. Tozaki H, Komoike J, Tada C, Maruyama T, Terabe A, Suzuki T, et al. Chitosan capsules for colon specific drug delivery: Improvement of insulin absorption from the rat colon. J Pharm Sci. 1997;86:1016-21.
23. Tozaki H, Fujita T, Odoriba T, Terabe A, Suzuki T, Tanaka C, et al. Colon specific delivery of R68070, a new thromboxane synthase inhibitor, using chitosan capsules: Therapeutic effect against 2, 4, 6,-trinitrobenzene sulphonic acid-induced ulcerative colitis in rats. Life Sci. 1999;64:1155-62.
24. Lapidus H, Lordi NG. Some factors affecting the release of a water-soluble drug from a compressed hydrophilic matrix. J Pharm Sci. 1966;55:840-3.
25. Nigalaye AG, Adusumilli P, Bolto S. Investigation of prolonged drug release from matrix formulations of chitosan. Drug Dev Ind Pharm. 1990;16:449-67.